New hope for lung cancer patients whose disease returned after targeted therapy
NCT ID NCT07279935
First seen Jan 04, 2026 · Last updated Apr 28, 2026 · Updated 12 times
Summary
This study is for people with a specific type of lung cancer (EGFR-mutant) that has spread to other parts of the body after they finished a targeted therapy called osimertinib. The goal is to see if adding chemotherapy to osimertinib can help control the cancer for longer. About 100 participants in China will receive the combination and be monitored for how long the cancer stays under control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
Beijing, 100021, China
-
Research Site
Beijing, 100044, China
-
Research Site
Beijing, 100142, China
-
Research Site
Chengdu, 610041, China
-
Research Site
Chongqing, 400016, China
-
Research Site
Fuzhou, 350001, China
-
Research Site
Fuzhou, 350005, China
-
Research Site
Guangzhou, 510080, China
-
Research Site
Guangzhou, 510100, China
-
Research Site
Guangzhou, 510289, China
-
Research Site
Hangzhou, 310020, China
-
Research Site
Hefei, 230022, China
-
Research Site
Hefei, 230031, China
-
Research Site
Jinan, 250014, China
-
Research Site
Kunming, 650118, China
-
Research Site
Nanchang, 330006, China
-
Research Site
Nanjing, 2100008, China
-
Research Site
Nanjing, 210009, China
-
Research Site
Ningbo, 315010, China
-
Research Site
Shanghai, 200030, China
-
Research Site
Shanghai, 200120, China
-
Research Site
Shanghai, 200433, China
-
Research Site
Shenyang, 110004, China
-
Research Site
Shenyang, 110042, China
-
Research Site
Tianjin, 300060, China
-
Research Site
Wuhan, 430022, China
-
Research Site
Wuhan, 430030, China
-
Research Site
Xi'an, 710004, China
-
Research Site
Xi'an, 710061, China
-
Research Site
Zhengzhou, 450008, China
Conditions
Explore the condition pages connected to this study.